Tango Therapeutics (TNGX) Other Working Capital Changes: 2020-2024
Historic Other Working Capital Changes for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to -$30.0 million.
- Tango Therapeutics' Other Working Capital Changes fell 363.65% to -$53.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.5 million, marking a year-over-year decrease of 112.58%. This contributed to the annual value of -$30.0 million for FY2024, which is 4.94% up from last year.
- Latest data reveals that Tango Therapeutics reported Other Working Capital Changes of -$30.0 million as of FY2024, which was up 4.94% from -$31.5 million recorded in FY2023.
- In the past 5 years, Tango Therapeutics' Other Working Capital Changes ranged from a high of $119.1 million in FY2020 and a low of -$31.5 million during FY2023.
- Over the past 3 years, Tango Therapeutics' median Other Working Capital Changes value was -$30.0 million (recorded in 2024), while the average stood at -$26.1 million.
- Per our database at Business Quant, Tango Therapeutics' Other Working Capital Changes crashed by 110.11% in 2021 and then climbed by 4.94% in 2024.
- Over the past 5 years, Tango Therapeutics' Other Working Capital Changes (Yearly) stood at $119.1 million in 2020, then crashed by 110.11% to -$12.0 million in 2021, then crashed by 40.01% to -$16.9 million in 2022, then tumbled by 86.99% to -$31.5 million in 2023, then rose by 4.94% to -$30.0 million in 2024.